A spider venom molecule being investigated by an IMB team has met critical benchmarks towards becoming a treatment for heart attack and stroke.
Associate Professor Nathan Palpant and Professor Glenn King explain the importance of Hi1a which is looking promising as a safe and effective drug.
Visit our website: [ Ссылка ]
